VAERS Explorer
Back to explore

Report #2859218

Received Sep 16, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Female
Age
Age unknown
State
—
Recovered
Unknown
Vaccinated
—
Onset
—
Days to onset
—
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
UNKVACCINE NOT SPECIFIED (NO BRAND NAME)UNKNOWN MANUFACTURERUNK—IM

Symptoms (1)

Headache

Symptom narrative

headache; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (headache) in an adult female patient who received mRNA-1283 (MNEXSPIKE PFS) for COVID-19 prophylaxis. No Medical History information was reported. On an unknown date, the patient received dose of mRNA-1283 (MNEXSPIKE PFS) (Intramuscular use) 1 dosage form. On an unknown date, the patient experienced HEADACHE (headache). The patient was treated with Paracetamol (Acetaminophen) for Headache, at an unspecified dose and frequency. At the time of the report, HEADACHE (headache) outcome was unknown. No concomitant medication was reported. The patient had the vaccine and took acetaminophen for her headache afterwards. It was unknown if the patient experienced any additional symptoms or events. Reporter causality was not reported. Reporter did not allow further contact